Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

A new project will use electronic health data from the UK’s National Health Service to assess the impact of GSK’s shingles vaccine on dementia risk reduction.

A Welsh health policy provided a rare opportunity for researchers to examine the vaccine's real-life impact on dementia risk.

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. A pair of recent studies has found that the ...

WASHINGTON — A vaccine to fight dementia? It turns out there may already be one – shots that prevent painful shingles also appear to protect aging brains. A new study found shingles ...

Emerging research suggests that shingles vaccination may also offer broader health benefits. A study published in April by a ...

Vaccination with GSK's recombinant shingles vaccine, Shingrix, could delay the onset of dementia, according to researchers in the UK. A study published in Nature Medicine suggests that people ...

Two new drug treatments for Alzheimer's will not be made available on the NHS, but there are several other medicines and ...